Joseph H. Pratt
Tufts University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph H. Pratt.
American Journal of Obstetrics and Gynecology | 1967
Edward M. Hanton; George D. Malkasian; Malcolm B. Dockerty; Joseph H. Pratt
Abstract Because endometriosis in young women may cause disabling pelvic symptoms and infertility, the authors reviewed the Mayo Clinic experience (1935 through 1964) to determine the frequency, relation to menarche, and outcome of endometriosis in such cases. Of 68 young patients having external endometriosis, 63 experienced menarche 5 to 10 years before diagnosis, 9 could not date menarche but were 21 or younger at diagnosis, and 6 had congenital obstruction to menstrual flow. Usually patients complained of dysmenorrhea or other pelvic pain, but 11 had no pelvic complaints. Only 3 complained chiefly of infertility. Ten patients initially had procedures ablating menstrual function, and 58 had conservative operations. One month to 25 years after conservative treatment, 15 patients required subsequent operation, radical in 12 cases. Since conservation of the childbearing function is the goal of treatment of young women, subsequent fertility (about 50 per cent in this series) is one measure of success.
Obstetrical & Gynecological Survey | 1975
Richard E. Symmonds; Joseph H. Pratt; Maurice J. Webb
In a series of 198 exenterative operations performed at the Mayo Clinic for various pelvic malignant lesions, a 5 year survival rate of 33 per cent was obtained. This rate is commendable, since almost 80 per cent of the operations were accomplished for recurrent malignancy. The diminished over-all operative mortality rate of 8.1 per cent, a reduction from 13.5 per cent (1950 through 1962) to 3 per cent (1963 through 1971), is attributed to better methods of urinary diversion and to better management of fluid replacement and of infectious complications. Major complications, excepting bowel fistula and obstruction, now can be controlled reasonably well. When more conservative and equally curative methods of therapy have been exhausted, all patients with pelvic malignancy (whether primary in cervix, vagina, bladder, urethra, rectum, or vulva) should be considered potential candidates for exenteration.
JAMA | 1964
Joseph S. Massee; John S. Welch; Joseph H. Pratt; Richard E. Symmonds
JAMA | 1955
David G. Decker; Robert E. Fricke; Joseph H. Pratt
Archives of Surgery | 1966
Adam R. Wychulis; Joseph H. Pratt
JAMA | 1946
Joseph P. McCRACKEN; Philip S. Owen; Joseph H. Pratt
Journal of Nutrition | 1934
Milton B. Handelsman; Lewis A. Golden; Joseph H. Pratt
Obstetrical & Gynecological Survey | 1965
Joseph S. Massee; John S. Welch; Joseph H. Pratt; Richard E. Symmonds
JAMA | 1942
Joseph H. Pratt
Archives of Surgery | 1964
Preston C. Manning; Joseph H. Pratt